Ms Fiona Pearce

Ms Fiona Pearce is a Senior Advisor to the Agency for Care Effectiveness (ACE), Singapore’s national HTA agency. As one of ACE’s founding staff, she was responsible for developing the HTA methods and processes which the agency uses to evaluate drugs and vaccines to inform national funding decisions. She was also involved in establishing Singapore’s national Rare Disease Fund in 2019, which provides long-term, financial support to patients with rare genetic conditions, and more recently, has established the Consumer Engagement and Education (CEE) workstream to encourage patient involvement in ACE’s work. 

She holds several appointments on different advisory boards in Singapore and is the Co-Chair of the HTAi Patient and Citizen Involvement in HTA Interest Group (PCIG).  

Prior to joining ACE, Fiona was a Technical Advisor at the National Institute for Health and Care Excellence (NICE), providing technical leadership on appraisals of medicines within the National Health Service (NHS) in England. She has also worked for the Cochrane Collaboration (renal group) in Australia and in the private sector in various market access functions in Australia and across the Asia-Pacific region.